TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from AbSci ( (ABSI) ).
On October 31, 2025, Absci Corporation executed a Letter Agreement with SBGH, LLC, amending a previous Merger Agreement from June 4, 2021, involving Totient, Inc. This agreement finalizes the distribution of Milestone Consideration, with former Totient stockholders receiving approximately $7.6 million and Absci receiving about $8.7 million, impacting the financial settlements under the original merger terms.
The most recent analyst rating on (ABSI) stock is a Hold with a $4.50 price target. To see the full list of analyst forecasts on AbSci stock, see the ABSI Stock Forecast page.
Spark’s Take on ABSI Stock
According to Spark, TipRanks’ AI Analyst, ABSI is a Neutral.
AbSci’s stock score is primarily impacted by its financial performance challenges, including negative profitability and cash flow issues. However, technical analysis suggests positive momentum, which is a significant strength. The earnings call provided some optimism with strategic partnerships and clinical progress, but valuation concerns due to negative earnings remain a risk.
To see Spark’s full report on ABSI stock, click here.
More about AbSci
Average Trading Volume: 5,257,060
Technical Sentiment Signal: Strong Buy
Current Market Cap: $614.5M
For a thorough assessment of ABSI stock, go to TipRanks’ Stock Analysis page.